Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In the SURPASS-2 trial, which compared tirzepatide to semaglutide 1 mg (a GLP-1 receptor agonist) over 40 weeks, participants receiving tirzepatide achieved A1C reductions of 2.01%, 2.24%, and 2.30% from baseline with the 5 mg, 10 mg, and 15 mg weekly doses, respectively
SAY GOODBYE TO EXCESS WEIGHT Discover how semaglutide weight loss can change your life
[11] [12] Women of childbearing potential should be aware that tirzepatide may reduce the effectiveness of oral contraceptives, particularly during the first 4 weeks after initiation and after each dose escalation
66% identified as Hispanic or Latino ethnicity
We also offer ongoing support and monitoring, including regular check-ins to assess progress and side effects, telemedicine options for convenient follow-ups, and access to a dedicated care team for questions and concerns
US$ 29.74
US$ 27.34
US$ 24.35
